Business Description
Adhera Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US56804Q3002
Description
Adhera Therapeutics Inc is an emerging specialty biotech company that is strategically evaluating its focus including a return to a drug discovery and development company.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -598.07 | |||||
| Debt-to-Equity | -0.41 | |||||
| Debt-to-EBITDA | -11.53 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 53.2 | |||||
| 3-Year FCF Growth Rate | 66.4 | |||||
| 3-Year Book Growth Rate | 27.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.4 | |||||
| 9-Day RSI | 36.48 | |||||
| 14-Day RSI | 37.19 | |||||
| 6-1 Month Momentum % | -28.57 | |||||
| 12-1 Month Momentum % | -87.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -79.8 | |||||
| Shareholder Yield % | -6280.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -3969.91 | |||||
| ROIC % | -8.16 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.53 | |||||
| EV-to-EBITDA | -11.53 | |||||
| EV-to-FCF | -15.18 | |||||
| Earnings Yield (Greenblatt) % | -8.67 | |||||
| FCF Yield % | -1929.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ATRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adhera Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.14 | ||
| Beta | 0.34 | ||
| Volatility % | 177.25 | ||
| 14-Day RSI | 37.19 | ||
| 14-Day ATR ($) | 0.001369 | ||
| 20-Day SMA ($) | 0.006895 | ||
| 12-1 Month Momentum % | -87.5 | ||
| 52-Week Range ($) | 0.0042 - 0.1499 | ||
| Shares Outstanding (Mil) | 7.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adhera Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adhera Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adhera Therapeutics Inc Frequently Asked Questions
What is Adhera Therapeutics Inc(ATRX)'s stock price today?
The current price of ATRX is $0.01. The 52 week high of ATRX is $0.15 and 52 week low is $0.00.
When is next earnings date of Adhera Therapeutics Inc(ATRX)?
The next earnings date of Adhera Therapeutics Inc(ATRX) is .
Does Adhera Therapeutics Inc(ATRX) pay dividends? If so, how much?
Adhera Therapeutics Inc(ATRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers